期刊文献+

白细胞介素-33对肝癌细胞迁移、侵袭能力和细胞骨架的影响 被引量:7

Effects of interleukin-33 on the invasion,migration and cytoskeleton of hepatoma carcinoma cell
下载PDF
导出
摘要 目的:探讨白细胞介素(IL)-33对肝癌细胞迁移能力、侵袭能力和细胞骨架的影响及其作用机制。方法:通过蛋白质印迹法检测肝癌细胞中β-链蛋白、基质金属蛋白酶(MMP)-2以及MMP-9蛋白表达水平,流式细胞仪分析肝癌细胞表面抗原分子的表达水平,附壁试验和细胞聚集试验分别检测肝癌细胞对细胞外基质的亲和力以及肝癌细胞的聚集能力,细胞迁移划痕实验和穿透小室法测定IL-33对肝癌细胞体外迁移侵袭能力的影响,高内涵细胞分析系统免疫荧光法检测IL-33对肝癌细胞骨架的影响。结果:在IL-33的作用下,肝癌细胞中β-链蛋白、MMP-2以及MMP-9蛋白的表达均显著下降(P<0.05),并有剂量和时间依赖性。与对照组相比,经IL-33作用后肝癌细胞间黏附分子-1、人类白细胞抗原-Ⅰ的表达率显著增加,且CD44表达显著下降(P<0.05);肝癌细胞对细胞外基质的亲和力及肝癌细胞聚集程度均降低(P<0.05);实验组肝癌细胞的微丝数量和细胞骨架的面积显著降低,且与剂量相关(P<0.05)。结论:IL-33能够有效抑制肝癌细胞的迁移和侵袭,并且有降低细胞骨架微丝数量和面积的作用。 Objective: To investigate the mechanism and effects of interleukin-33(IL-33) on the migration,invasion and cytoskeleton of human hepatoma carcinoma cells. Methods: The protein expression levels of β-catenin,matrix metalloproteinase-2(MMP-2) and matrix metalloproteinase-9(MMP-9) in hepatoma carcinoma cells were detected by Western blotting. The expression of antigenic molecules was analyzed by flow cytometer. The tumor cell binding affinity to extracellular matrix components and the degree of homotypic aggregation were measured by cell attachment and aggregation assay,respectively. The invasive and migratory abilities of IL-33 were detected by Transwell migration assay and wound healing assay,respectively. The effect of IL-33 on cytoskeleton was evaluated by high intension cell analysis system. Results: The expression of β-catenin,MMP-2 and MMP-9 were significant decreased in experimental group than those in control group in a dose and time dependent manner after the IL-33 treatment(P 〈 0. 05). Compared with control group,the expression of ICAM-1,HLA-Ⅰ increased significantly while the CD44 was significantly decreased(P 〈 0. 05). And the binding affinity to extracellular matrix components and the degree of homotypic aggregation were significantly decreased after IL-33 treatment. The microfilament cytoskeleton and the area of cytoskeleton decreased more significantly than those in control group(P 〈 0. 05). Conclusion:The IL-33 can effectively suppress the invasion and migration of hepatoma carcinoma cell,and reduce the amount of microfilament and the area of cytoskeleton.
作者 李凡 夏兵祥 徐健 张业伟 LI Fan, XIA Bing-xiang, XU Jian, ZHANG Ye-wei(Department of General Surgery, Nanjing Medical University Affiliated Cancer Hospital, Nanjing 210009, Chin)
出处 《东南大学学报(医学版)》 CAS 2018年第3期365-371,共7页 Journal of Southeast University(Medical Science Edition)
基金 国家自然科学基金面上项目(61371066) 江苏省"333高层次人才培养工程"第二层次项目(BRA2016508) 江苏省六大高峰人才项目(WSW041) 江苏省社会发展基金面上项目(BE2015720)
关键词 白细胞介素-33 肝癌细胞 细胞迁移侵袭 细胞骨架 interleukin-33 hepatoma carcinoma cell invasion and metastasis of cell cytoskeleton
  • 相关文献

参考文献7

二级参考文献63

  • 1李志清.CD11/CD18在中性粒细胞对内皮细胞粘附及损伤中作用[J].重庆医学,1997,26(2):85-88. 被引量:3
  • 2Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA, et al. Identification of selective inhibitors of cancer stern cells by high-throughput screening. Cell 2009, 138(4): 645-59.
  • 3Kim KY, Yu SN, Lee SY, Chun SS, Choi YL, Park YM, et al. Salinomycin-induced apoptosis of human prostate cancer cells due to accumulated reactive oxygen species and mitochondrial membrane depolarization. Biochem Biophys Res Commun 2011, 413(1): 80-6.
  • 4Zhang GN, Liang Y, Zhou L J, Chen SP, Chen G, Zhang TP, et al. Combination of salinomycin and gemcitabine eliminates pancreatic cancer cells. Cancer Lett 2011, 313(2): 137-44.
  • 5Kim JH, Chae M, Kim WK, Kim YJ, Kang HS, Kim HS, et al. Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 protein. Br J Pharmacol 2011, 162(3): 773-84.
  • 6Fuchs D, Daniel V, Sadeghi M, Opelz G, Naujokat C. Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1 a cells. Biochem Biophys Res Commun 2010, 394(4): 1098-104.
  • 7Yilmaz M, Christofori G, Lehembre F. Distinct mechanisms of tumor invasion and metastasis. Trends Mol Med 2007, 13(12): 535-41.
  • 8Costantini S, Di Bemardo G, Cammarota M, Castello G, Colonna G. Gene expression signature of human HepG2 cell line. Gene 2013, 15(2): 335-45.
  • 9Yilmaz M, Christofori G. Mechanisms of motility in metasta- sizing cells. Mol Cancer Res 2010, 8(5): 629-42.
  • 10Suzuki T, Yano H, Nakashima Y. Beta-catenin expression in hepatocellular carcinoma: A possible participation of beta-catenin in the dedifferentiation process. J Gastroenterol Hepatol 2002, 17(9): 994-1000.

共引文献39

同被引文献65

引证文献7

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部